LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New DNA Microarray System

By Biotechdaily staff writers
Posted on 10 Oct 2002
A new DNA microarray system combines ease of operation, a hybridization incubator that permits highly reproducible hybridization reactions ten times faster than other methods, and an image acquisition system. The system was exhibited at the annual meeting of the Japanese Cancer Society in Tokyo (Japan).

Called FD10, the microarray is based on the PamChip developed by PamGene International B.V. (S-Hertogenbosch, The Netherlands). The FD10 was jointly developed by PamGene and Olympus Optical Co. (Tokyo, Japan) and is being marketed by Olympus. The target market comprises universities and other academic research institutions, pharmacuetical firms, and food manufacturers.

"Combining the strengths of our PamChip--robustness, speed, and kinetic readout—with the ease of use and sensitivity of the FD10 is an excellent starting point for a successful entry in the microarray market,” said Tim Kievits, CEO of PamGene. The company was formed in 2001, with the objective of becoming a biodiscovery company for pharmaceutical research and development.




Related Links:
PamGene
Olympus Optical

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
10 Oct 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
10 Oct 2002  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
10 Oct 2002  |   BioResearch